34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details
臨床試験数 : 137 / 薬物数 : 213 - (DrugBank : 76) / 標的遺伝子数 : 87 - 標的パスウェイ数 : 200
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03079999 (ClinicalTrials.gov) | June 11, 2018 | 6/3/2017 | Study of Aspirin in Patients With Vestibular Schwannoma | Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas | Vestibular Schwannoma;Acoustic Neuroma;Neurofibromatosis 2 | Drug: Aspirin;Drug: Placebo | Massachusetts Eye and Ear Infirmary | United States Department of Defense;Massachusetts General Hospital | Recruiting | 12 Years | N/A | All | 300 | Phase 2 | United States |